Ep. 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay

1500.455 - 1520.423 Dr. Rana McKay

I mean, like I said, DEXA scan for select individuals, depending on duration of therapy, making sure they're up to date with their lipid panel, making sure they've had a hemoglobin A1C, if you've looked at their fasting glucose, and somebody is tracking that, you know, some patients may warrant, you know, being on a statin or being on an aspirin if they're high risk when they go on ADT.